Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse
Chandra Nataraj, … , Beverly H. Koller, Thomas M. Coffman
Chandra Nataraj, … , Beverly H. Koller, Thomas M. Coffman
Published October 15, 2001
Citation Information: J Clin Invest. 2001;108(8):1229-1235. https://doi.org/10.1172/JCI13640.
View: Text | PDF
Article

Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse

  • Text
  • PDF
Abstract

Production of prostaglandin E2 (PGE2) is enhanced during inflammation, and this lipid mediator can dramatically modulate immune responses. There are four receptors for PGE2 (EP1–EP4) with unique patterns of expression and different coupling to intracellular signaling pathways. To identify the EP receptors that regulate cellular immune responses, we used mouse lines in which the genes encoding each of the four EP receptors were disrupted by gene targeting. Using the mixed lymphocyte response (MLR) as a model cellular immune response, we confirmed that PGE2 has potent antiproliferative effects on wild-type responder cells. The absence of either the EP1 or EP3 receptors did not alter the inhibitory response to PGE2 in the MLR. In contrast, when responder cells lacked the EP2 receptor, PGE2 had little effect on proliferation. Modest resistance to PGE2 was also observed in EP4–/– responder cells. Reconstitution experiments suggest that EP2 receptors primarily inhibit the MLR through direct actions on T cells. Furthermore, PGE2 modulates macrophage function by activating the EP4 receptor and thereby inhibiting cytokine release. Thus, PGE2 regulates cellular immune responses through distinct EP receptors on different immune cell populations: EP2 receptors directly inhibit T cell proliferation while EP2 and EP4 receptors regulate antigen presenting cells functions.

Authors

Chandra Nataraj, Dennis W. Thomas, Stephen L. Tilley, MyTrang Nguyen, Roslyn Mannon, Beverly H. Koller, Thomas M. Coffman

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Total
Citations: 2 3 2 5 6 4 2 9 4 6 12 2 9 10 4 3 6 7 4 2 3 3 2 1 111
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (111)

Title and authors Publication Year
Targeting KRAS: from metabolic regulation to cancer treatment
Shi Y, Zheng H, Wang T, Zhou S, Zhao S, Li M, Cao B
Molecular Cancer 2025
Role of EP4 factor in paediatric type 1 diabetes mellitus: a comprehensive review focusing on the honeymoon period
Taheri F, Panahi N, Vahidi A, Asadi M, Amoli MM, Goharifar N
Pediatric Endocrinology, Diabetes, and Metabolism 2025
Exploration of Molecular Mechanisms of Immunity in the Pacific Oyster (Crassostrea gigas) in Response to Vibrio alginolyticus Invasion
Zhang E, Li Z, Dong L, Feng Y, Sun G, Xu X, Wang Z, Cui C, Wang W, Yang J
Animals : an open access journal from MDPI 2024
IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo
Ghimire S, Xue B, Li K, Gannon RM, Wohlford-Lenane CL, Thurman AL, Gong H, Necker GC, Zheng J, Meyerholz DK, Perlman S, McCray PB Jr, Pezzulo AA
2024
SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor
Alnouri MW, Roquid KA, Bonnavion R, Cho H, Heering J, Kwon J, Jäger Y, Wang S, Günther S, Wettschureck N, Geisslinger G, Gurke R, Müller CE, Proschak E, Offermanns S
Proceedings of the National Academy of Sciences of the United States of America 2024
Genetically predicted 486 blood metabolites concerning risk of systemic lupus erythematosus: a Mendelian randomization study.
Zhao L, Wu R, Wu Z, Liu X, Li J, Zhang L, Zhang S
Scientific Reports 2023
Remodeling the immune microenvironment for gastric cancer therapy through antagonism of prostaglandin E2 receptor 4
Guo M, Hu P, Xie J, Tang K, Hu S, Sun J, He Y, Li J, Lu W, Liu H, Liu M, Yi Z, Peng S
Genes & Diseases 2023
Cyclooxygenase-2 in adipose tissue macrophages limits adipose tissue dysfunction in obese mice
Yu Pan, Shirong Cao, Jiaqi Tang, Juan P Arroyo, Andrew S Terker, Yinqiu Wang, Aolei Niu, Xiaofeng Fan, Suwan Wang, Yahua Zhang, Ming Jiang, David H. Wasserman, Ming-Zhi Zhang, Raymond Harris
Journal of Clinical Investigation 2022
Long-Chain Polyunsaturated Fatty Acids Supplementation and Respiratory Infections
V Cosmi, A Mazzocchi, S Turolo, M Syren, G Milani, C Agostoni
Annals of Nutrition and Metabolism 2022
Prostaglandin E-major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase.
Sakurai T, Akita Y, Miyashita H, Miyazaki R, Maruyama Y, Saito T, Shimada M, Yamasaki T, Arhihiro S, Kato T, Matsuura T, Ikegami M, Okayasu I, Saruta M
Journal of Gastroenterology and Hepatology 2022
Cell‐Specific Actions of the Prostaglandin E‐Prostanoid Receptor 4 Attenuating Hypertension: A Dominant Role for Kidney Epithelial Cells Compared With Macrophages
Yang T, Song C, Ralph DL, Andrews P, Sparks MA, Koller BH, McDonough AA, Coffman TM
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2022
Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease
Sakurai T, Saruta M
Digestion 2022
Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury
Y Pan, S Cao, AS Terker, J Tang, K Sasaki, Y Wang, A Niu, W Luo, X Fan, S Wang, MH Wilson, MZ Zhang, RC Harris
Kidney International 2021
Human multipotent adult progenitor cells effectively reduce graft‐vs‐host disease while preserving graft‐vs‐leukemia activity
L Metheny, S Eid, P Wuttisarnwattana, JJ Auletta, C Liu, AV Dervort, C Paez, ZH Lee, D Wilson, HM Lazarus, R Deans, WV Hof, Y Ktena, KR Cooke
Stem Cells 2021
Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome
S Turolo, A Edefonti, A Mazzocchi, ML Syren, W Morello, C Agostoni, G Montini
International journal of molecular sciences 2021
Agonism of Prostaglandin E2 Receptor 4 Ameliorates Tubulointerstitial Injury in Nephrotoxic Serum Nephritis in Mice
I Aringer, K Artinger, C Schabhüttl, T Bärnthaler, AA Mooslechner, A Kirsch, M Pollheimer, P Eller, AR Rosenkranz, A Heinemann, K Eller
Journal of Clinical Medicine 2021
Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma
WH Nasry, CK Martin
Frontiers in Oncology 2021
Indomethacin Treatment Post-irradiation Improves Mouse Parotid Salivary Gland Function via Modulation of Prostaglandin E2 Signaling
KE Gilman, JM Camden, LT Woods, GA Weisman, KH Limesand
Frontiers in Bioengineering and Biotechnology 2021
EP4 activation ameliorates liver ischemia/reperfusion injury via ERK1/2‑GSK3β‑dependent MPTP inhibition
LL Cai, HT Xu, QL Wang, YQ Zhang, W Chen, DY Zheng, F Liu, HB Yuan, YH Li, HL Fu
International journal of molecular medicine 2020
Unbalanced production of LTB 4 /PGE 2 driven by diabetes increases susceptibility to cutaneous leishmaniasis
I Bonyek-Silva, S Nunes, RL Santos, FR Lima, A Lago, J Silva, LP Carvalho, SM Arruda, HC Serezani, EM Carvalho, CI Brodskyn, NM Tavares
Emerging Microbes & Infections 2020
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
W Lu, W Yu, J He, W Liu, J Yang, X Lin, Y Zhang, X Wang, W Jiang, J Luo, Q Zhang, H Yang, S Peng, Z Yi, S Ren, J Chen, S Siwko, R Nussinov, F Cheng, H Zhang, M Liu
EMBO Molecular Medicine 2020
A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes.
Woodward DF, Wang JW, Spada CS, Carling RW, Martos JL, Pettit S, Kangasmetsa J, Waterbury LD, Lawrence M, Hu W, Poloso NJ
2020
The affinity, intrinsic activity and selectivity of a structurally novel EP 2 receptor agonist at human prostanoid receptors: Non-prostanoid structure EP 2 agonist
RA Coleman, AJ Woodrooffe, KL Clark, CB Toris, S Fan, JW Wang, DF Woodward
British Journal of Pharmacology 2019
Prostaglandin E2 and an EP4 receptor agonist inhibit LPS-Induced monocyte chemotactic protein 5 production and secretion in mouse cardiac fibroblasts via Akt and NF-κB signaling
TD Bryson, J Ross, E Peterson, P Harding
Prostaglandins & Other Lipid Mediators 2019
Restoration of the type I IFN-IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in non-obese diabetic mice
M.Jubayer Rahman, kameron Rodrigues, Juan A. Quiel, Yi Liu, Vipul Bhargava, Yongge Zhao, Chie Iwamura, Han-Yu Shih, Annie Lau-Kilby, Allison Malloy, Timothy Thoner, Kristin Tarbell
JCI Insight 2018
Eicosanoid Control Over Antigen Presenting Cells in Asthma
N Debeuf, BN Lambrecht
Frontiers in immunology 2018
Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development
WG Robichaux, X Cheng
Physiological reviews 2018
Cyclooxygenase-1 and -2 Play Contrasting Roles in Listeria -Stimulated Immunity
E Theisen, CE McDougal, M Nakanishi, DM Stevenson, D Amador-Noguez, DW Rosenberg, LJ Knoll, JD Sauer
Journal of immunology (Baltimore, Md. : 1950) 2018
Listeria monocytogenes: The Impact of Cell Death on Infection and Immunity
C McDougal, JD Sauer
Pathogens 2018
Immunomodulatory Effects of CP-25 on Splenic T Cells of Rats with Adjuvant Arthritis
Y Wang, C Han, D Cui, T Luo, Y Li, Y Zhang, Y Ma, W Wei
Inflammation 2018
Improvement in spirometry and oxygenation of chronic obstructive pulmonary disease during pregnancy
D Gothi, RB Sah, A Teotia, S Yadav
Lung India : official organ of Indian Chest Society 2018
Screening for Biologically Annotated Drugs That Trigger Triacylglycerol Accumulation in the Diatom Phaeodactylum
M Conte, J Lupette, K Seddiki, C Meï, LJ Dolch, V Gros, C Barette, F Rébeillé, J Jouhet, E Maréchal
Plant physiology 2018
Cytotoxic and inflammatory potential of a phospholipase A2 from Bothrops jararaca snake venom
RC Cedro, DL Menaldo, TR Costa, KF Zoccal, MA Sartim, NA Santos-Filho, LH Faccioli, SV Sampaio
Journal of Venomous Animals and Toxins 2018
De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
MR Lopes, JK Pereira, PM Campos, JA Machado-Neto, F Traina, ST Saad, P Favaro
Scientific Reports 2017
Analgesic and anti-inflammatory properties of novel, selective, and potent EP4 receptor antagonists
S Chandrasekhar, XP Yu, AK Harvey, JL Oskins, C Lin, X Wang, MJ Blanco, MJ Fisher, SL Kuklish, MA Schiffler, T Vetman, AM Warshawsky, JS York, AM Bendele, MG Chambers
Pharmacology Research & Perspectives 2017
Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E 2 Receptor EP4 Pathway
YA Hong, KJ Yang, SY Jung, KC Park, H Choi, JM Oh, SJ Lee, YK Chang, CW Park, CW Yang, SY Kim, HS Hwang
Oxidative medicine and cellular longevity 2017
Activation of PGE2/EP2 and PGE2/EP4 signaling pathways positively regulate the level of PD‑1 in infiltrating CD8+ T cells in patients with lung cancer
J Wang, L Zhang, D Kang, D Yang, Y Tang
Oncology Letters 2017
Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy
X Wang, B Yao, Y Wang, X Fan, S Wang, A Niu, H Yang, A Fogo, MZ Zhang, RC Harris
Diabetes 2016
Human Mesenchymal Stem Cell-Derived Microvesicles Prevent the Rupture of Intracranial Aneurysm in Part by Suppression of Mast Cell Activation Via a PGE2-Dependent Mechanism: MSC-Derived MVs Stabilize Intracranial Aneurysm
J Liu, A Kuwabara, Y Kamio, S Hu, J Park, T Hashimoto, JW Lee
Stem Cells 2016
Transcriptional Profiling of Th2 Cells Identifies Pathogenic Features Associated with Asthma
G Seumois, J Zapardiel-Gonzalo, B White, D Singh, V Schulten, M Dillon, D Hinz, DH Broide, A Sette, B Peters, P Vijayanand
Journal of immunology (Baltimore, Md. : 1950) 2016
Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes
SN Vallerie, F Kramer, S Barnhart, JE Kanter, RM Breyer, KI Andreasson, KE Bornfeldt, M Aikawa
PloS one 2016
Molecular Characterization of E-Type Prostanoid Receptor 4 (EP4) from Ayu (Plecoglossus altivelis) and Its Functional Analysis in the Monocytes/Macrophages
YJ Rong, XJ Lu, J Chen, BL Diaz
PloS one 2016
A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs
MI Carvalho, R Silva-Carvalho, I Pires, J Prada, R Bianchini, E Jensen-Jarolim, FL Queiroga
BioMed Research International 2016
Skin tight: macrophage-specific COX-2 induction links salt handling in kidney and skin
Johannes Stegbauer, Thomas M. Coffman
Journal of Clinical Investigation 2015
Inhibition of Cyclooxygenase-2 Derived Prostaglandin E2 Signaling in Hematopoietic Cells Results in Salt-Sensitive Hypertension
Ming-zhi Zhang, Bing Yao, Yinqiu Wang, shilin Yang, Suwan Wang, Xiaofeng Fan, Harris Raymond Clement
Journal of Clinical Investigation 2015
Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis
Jian Chang, Jean Vacher, Bing Yao, Xiaofeng Fan, Bi-xiang Zhang, Raymond C. Harris, Ming-zhi Zhang
Oncotarget 2015
Environmental immune disruptors, inflammation and cancer risk
PA Thompson, M Khatami, CJ Baglole, J Sun, SA Harris, EY Moon, F Al-Mulla, R Al-Temaimi, DG Brown, AM Colacci, C Mondello, J Raju, EP Ryan, J Woodrick, AI Scovassi, N Singh, M Vaccari, R Roy, S Forte, L Memeo, HK Salem, A Amedei, RA Hamid, L Lowe, T Guarnieri, WH Bisson
Carcinogenesis 2015
Epigenetic Regulations of Inflammatory Cyclooxygenase-Derived Prostanoids: Molecular Basis and Pathophysiological Consequences
H Harizi
Mediators of Inflammation 2015
Identification of candidate genes and mutations in QTL regions for immune responses in chicken
M Siwek, A Slawinska, M Rydzanicz, J Wesoly, M Fraszczak, T Suchocki, J Skiba, K Skiba, J Szyda
Animal Genetics 2015
Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection
K Kotzamanis, A Angulo, P Ghazal
Medical Microbiology and Immunology 2015
Anti-inflammatory effects of PGE 2 in the lung: role of the EP 4 receptor subtype
MA Birrell, SA Maher, B Dekkak, V Jones, S Wong, P Brook, MG Belvisi
Thorax 2015
PGE2 Elevates IL-23 Production in Human Dendritic Cells via a cAMP Dependent Pathway
Q Shi, Z Yin, B Zhao, F Sun, H Yu, X Yin, L Zhang, S Wang
Mediators of Inflammation 2015
Prostaglandin E2 Production and T Cell Function in Mouse Adenovirus Type 1 Infection following Allogeneic Bone Marrow Transplantation
MK McCarthy, MC Procario, CA Wilke, BB Moore, JB Weinberg, J Kanellopoulos
PloS one 2015
Prostanoids in Asthma and COPD
Z Zaslona, M Peters-Golden
Chest 2015
Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?: PGE 2 receptors as targets in cancer therapy
G O'Callaghan, A Houston
British Journal of Pharmacology 2015
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells
Z Zasłona, K Okunishi, E Bourdonnay, R Domingo-Gonzalez, BB Moore, NW Lukacs, DM Aronoff, M Peters-Golden
Journal of Allergy and Clinical Immunology 2014
The fish oil ingredient, docosahexaenoic acid, activates cytosolic phospholipase A 2 via GPR120 receptor to produce prostaglandin E 2 and plays an anti-inflammatory role in macrophages
Y Liu, LY Chen, M Sokolowska, M Eberlein, S Alsaaty, A Martinez-Anton, C Logun, HY Qi, JH Shelhamer
Immunology 2014
Prostaglandin E₂ promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase
C Yao, T Hirata, K Soontrapa, X Ma, H Takemori, S Narumiya
Nature Communications 2013
Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology
H Harizi
Cellular and Molecular Immunology 2013
Proinflammatory and immunoregulatory roles of eicosanoids in T cells
AM Lone, K Taskén
Frontiers in immunology 2013
The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity
H Harizi
BioMed Research International 2013
Exosome-like nanoparticles from intestinal mucosal cells carry prostaglandin E2 and suppress activation of liver NKT cells
ZB Deng, X Zhuang, S Ju, X Xiang, J Mu, Y Liu, H Jiang, L Zhang, J Mobley, C McClain, W Feng, W Grizzle, J Yan, D Miller, M Kronenberg, HG Zhang
Journal of immunology (Baltimore, Md. : 1950) 2013
Cyclooxygenase-2 and Inflammation Mediators Have a Crucial Role in Reflux-Related Esophageal Histological Changes and Barrett’s Esophagus
A Taddei, V Fabbroni, A Pini, L Lucarini, MN Ringressi, O Fantappiè, D Bani, L Messerini, E Masini, P Bechi
Digestive Diseases and Sciences 2013
Prostaglandin E2-EP3 axis in fine-tuning excessive skin inflammation by restricting dendritic cell functions
N Shiraishi, T Nomura, H Tanizaki, S Nakajima, S Narumiya, Y Miyachi, Y Tokura, K Kabashima
PloS one 2013
Eicosanoid modulation by the short-chain fatty acid n-butyrate in human monocytes
JJ Kovarik, MA Hölzl, J Hofer, P Waidhofer-Söllner, Y Sobanov, R Koeffel, MD Saemann, D Mechtcheriakova, GJ Zlabinger
Immunology 2013
Prostaglandin E2 in tick saliva regulates macrophage cell migration and cytokine profile
NM Poole, G Mamidanna, RA Smith, LB Coons, JA Cole
Parasites & vectors 2013
Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling
Z Zasłona, CH Serezani, K Okunishi, DM Aronoff, M Peters-Golden
Blood 2012
Prostaglandin E 2 Produced by the Lung Augments the Effector Phase of Allergic Inflammation
RJ Church, LA Jania, BH Koller
Journal of immunology (Baltimore, Md. : 1950) 2012
Mast Cell Chemotaxis – Chemoattractants and Signaling Pathways
I Halova, L Draberova, P Draber
Frontiers in immunology 2012
8,9-Epoxyeicosatrienoic Acid Inhibits Antibody Production of B Lymphocytes in Mice
Y Gao, J Feng, K Ma, Z Zhou, Y Zhu, Q Xu, X Wang
PloS one 2012
An Important Role of Prostanoid Receptor EP2 in Host Resistance to Mycobacterium tuberculosis Infection in Mice
V Kaul, D Bhattacharya, Y Singh, LV Kaer, M Peters-Golden, WR Bishai, G Das
The Journal of Infectious Diseases 2012
Lipopolysaccharide-induced Cyclooxygenase-2 Expression in Mouse Transformed Clara Cells
RD Britt, ML Locy, TE Tipple, LD Nelin, LK Rogers
Cellular Physiology and Biochemistry 2012
Anti-inflammation Therapy by Activation of Prostaglandin EP4 Receptor in Cardiovascular and Other Inflammatory Diseases:
EH Tang, P Libby, PM Vanhoutte, A Xu
Journal of Cardiovascular Pharmacology 2012
Inhibition of EP4 Signaling Attenuates Aortic Aneurysm Formation
U Yokoyama, R Ishiwata, MH Jin, Y Kato, O Suzuki, H Jin, Y Ichikawa, S Kumagaya, Y Katayama, T Fujita, S Okumura, M Sato, Y Sugimoto, H Aoki, S Suzuki, M Masuda, S Minamisawa, Y Ishikawa, MR Kano
PloS one 2012
Prostaglandin E 2 Induces Oncostatin M Expression in Human Chronic Wound Macrophages through Axl Receptor Tyrosine Kinase Pathway
K Ganesh, A Das, R Dickerson, S Khanna, NL Parinandi, GM Gordillo, CK Sen, S Roy
Journal of immunology (Baltimore, Md. : 1950) 2012
Prostaglandin E 2 Affects T Cell Responses through Modulation of CD46 Expression
K Kickler, K Maltby, SN Choileain, J Stephen, S Wright, DA Hafler, HN Jabbour, AL Astier
Journal of immunology (Baltimore, Md. : 1950) 2012
Neuronal and vascular protection by the prostaglandin E2 EP4 receptor in a mouse model of cerebral ischemia
Xibin Liang, Lu Lin, Nathaniel Woodling, Qian Wang, Christoph Anacker, Tingting Pan, Milton Merchant, Katrin Andreasson
Journal of Clinical Investigation 2011
Prostaglandin E2 and T cells: friends or foes?
V Sreeramkumar, M Fresno, N Cuesta
Immunology and Cell Biology 2011
Prostaglandin E2 EP receptors as therapeutic targets in breast cancer
J Reader, D Holt, A Fulton
Cancer and Metastasis Reviews 2011
Deconstructing Tick Saliva
CJ Oliveira, A Sá-Nunes, IM Francischetti, V Carregaro, E Anatriello, JS Silva, IK de Santos, JM Ribeiro, BR Ferreira
The Journal of biological chemistry 2011
The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity
J Shi, J Johansson, NS Woodling, Q Wang, TJ Montine, K Andreasson
Journal of immunology (Baltimore, Md. : 1950) 2010
Prostaglandin E2-dependent IL-23 production in aged murine dendritic cells
RG Myer, RE Mezayen, KP High
Experimental Gerontology 2010
Induction of TGF-β1, Not Regulatory T Cells, Impairs Antiviral Immunity in the Lung following Bone Marrow Transplant
SM Coomes, CA Wilke, TA Moore, BB Moore
Journal of immunology (Baltimore, Md. : 1950) 2010
Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response
S Alzabin, S Pyarajan, H Yee, F Kiefer, A Suzuki, S Burakoff, S Sawasdikosol
Cancer Immunology, Immunotherapy 2009
Prostanoid receptor antagonists: development strategies and therapeutic applications
RL Jones, MA Giembycz, DF Woodward
British Journal of Pharmacology 2009
Prostaglandin E2–EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion
C Yao, D Sakata, Y Esaki, Y Li, T Matsuoka, K Kuroiwa, Y Sugimoto, S Narumiya
Nature Medicine 2009
Protease-activated receptors and prostaglandins in inflammatory lung disease
T Peters, PJ Henry
British Journal of Pharmacology 2009
Prostanoids and inflammation: a new concept arising from receptor knockout mice
S Narumiya
Journal of Molecular Medicine 2009
Current concepts regarding the pathogenesis of necrotizing enterocolitis
M Petrosyan, YS Guner, M Williams, A Grishin, HR Ford
Pediatric Surgery International 2009
Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury
K Hishikari, J Suzuki, M Ogawa, K Isobe, T Takahashi, M Onishi, K Takayama, M Isobe
Cardiovascular Research 2008
Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death
M Chen, M Divangahi, H Gan, DS Shin, S Hong, DM Lee, CN Serhan, SM Behar, HG Remold
Journal of Experimental Medicine 2008
Macrophage EP4 Deficiency Increases Apoptosis and Suppresses Early Atherosclerosis
VR Babaev, JD Chew, L Ding, S Davis, MD Breyer, RM Breyer, JA Oates, S Fazio, MF Linton
Cell Metabolism 2008
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion
C Chizzolini, R Chicheportiche, M Alvarez, C Rham, P Roux-Lombard, S Ferrari-Lacraz, JM Dayer
Blood 2008
Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function
N Kundu, X Ma, D Holt, O Goloubeva, S Ostrand-Rosenberg, AM Fulton
Breast Cancer Research and Treatment 2008
Respiratory Francisella tularensis Live Vaccine Strain Infection Induces Th17 Cells and Prostaglandin E 2 , Which Inhibits Generation of Gamma Interferon-Positive T Cells
MD Woolard, LL Hensley, TH Kawula, JA Frelinger
Infection and immunity 2008
Lung Resident Mesenchymal Stem Cells Isolated From Human Lung Allografts Inhibit T Cell Proliferation via a Soluble Mediator
Jarvinen L, Badri L, Wettlaufer S, Ohtsuka T, Standiford TJ, Toews GB, Pinsky DJ, Peters-Golden M, Lama VN
Journal of immunology (Baltimore, Md. : 1950) 2008
Conditional regulation of cyclooxygenase-2 in tracheobronchial epithelial cells modulates pulmonary immunity: Regulation of COX-2 expression in the lung
GY Park, N Hu, X Wang, RT Sadikot, FE Yull, M Joo, RS Peebles, TS Blackwell, JW Christman
Clinical & Experimental Immunology 2007
P2 purinergic receptor modulation of cytokine production
CA Gabel
Purinergic Signalling 2007
Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1
M Nagamachi, D Sakata, K Kabashima, T Furuyashiki, T Murata, E Segi-Nishida, K Soontrapa, T Matsuoka, Y Miyachi, S Narumiya
Journal of Experimental Medicine 2007
Elevated expression of prostaglandin receptor and increased release of prostaglandin E2 maintain the survival of CD45RO+ T cells in the inflamed human pleural space
E Pace, TF Bruno, B Berenger, CH Mody, M Melis, M Ferraro, A Tipa, A Bruno, M Profita, G Bonsignore, M Gjomarkaj
Immunology 2007
Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases
GY Park
American journal of physiology. Lung cellular and molecular physiology 2006
E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2
M Okano, Y Sugata, T Fujiwara, R Matsumoto, M Nishibori, K Shimizu, M Maeda, Y Kimura, S Kariya, H Hattori, M Yokoyama, K Kino, K Nishizaki
Immunology 2006
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
D Braun, RS Longman, ML Albert
Blood 2005
Stimulation of protease-activated receptor-2 inhibits airway eosinophilia, hyperresponsiveness and bronchoconstriction in a murine model of allergic inflammation
BA Campo, PJ Henry
British Journal of Pharmacology 2005
Effect of Ciprofloxacin-Induced Prostaglandin E 2 on Interleukin-18-Treated Monocytes
HK Takahashi, H Iwagaki, D Xue, G Katsuno, S Sugita, K Mizuno, S Mori, S Saito, T Yoshino, N Tanaka, M Nishibori
Antimicrobial agents and chemotherapy 2005
Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis
W Walker, D Rotondo
Immunology 2004
Cyclo-oxygenase type 2-dependent prostaglandin E2 secretion is involved in retrovirus-induced T-cell dysfunction in mice
S Rahmouni, EM Aandahl, B Nayjib, M Zeddou, S Giannini, M Verlaet, R Greimers, J Boniver, K Tasken, M Moutschen
Biochemical Journal 2004
Differential modulation of prostaglandin receptor mRNA abundance by prostaglandins in primary cultured rat hepatocytes.
Pérez S, Maldonado EN, Aspichueta P, Ochoa B, Chico Y
Molecular and Cellular Biochemistry 2004
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor
Li Yang Noboru Yamagata Rajwardhan Yadav Suzanne Brandon Regina L. Courtney Jason D. Morrow Yu Shyr Mark Boothby Sebastian Joyce David P. Carbone Richard M. Breyer
Journal of Clinical Investigation 2003
Prostaglandin E2 mediates growth arrest in NFS-60 cells by down-regulating interleukin-6 receptor expression
KI de Silva, AN Daud, JP Deng, SB Jones, RL Gamelli, R Shankar
Biochemical Journal 2003
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis
Jennifer M. McCoy, Joan R. Wicks, Laurent P. Audoly
Journal of Clinical Investigation 2002

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts